
Defining Excellence in Cardiac Care: HeartSync’s PMA Journey
In July 2023, Nissha Medical Technologies (NMT) achieved a significant milestone: Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for its HeartSync line of disposable defibrillation electrodes. This marked the culmination of years of collaborative efforts across teams within NMT and external partners, solidifying the company’s reputation as a leading global manufacturer of disposable medical electrodes.A Foundation of ExcellenceThe journey of HeartSync began with the development of a high-quality defibrillation electrode by the HeartSync company, recognized for its safety, efficacy, and cost-effectiveness. NMT identified the potential of HeartSync’s products early on, leading to its acquisition in May 2019. This integration complemented NMT’s core expertise in disposable, wearable medical technologies and positioned HeartSync as a key brand within the company’s portfolio.Expanding Market PresencePrior to PMA approval, HeartSync products,…